🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3, multicenter, randomized, parallel-group, double-blind, a...
Status
Completed
Location
TESARO Inc
Start Date
2012-02
Trial ID
NCT01499849
Treatments Being Tested
This is a Phase 3, multicenter, randomized, parallel-group, double-blind, a...
Status
Completed
Location
TESARO Inc
Start Date
2012-02
Trial ID
NCT01500213
Treatments Being Tested
This is a multicenter, randomized, controlled study in women who are having...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00539721
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of singl...
Status
Completed
Location
Parexel
Start Date
2015-01
Trial ID
NCT02382666
Treatments Being Tested
This is an open-label, randomized, single-dose, single-center, parallel-gro...
Status
Completed
Location
Parexel
Start Date
2014-09
Trial ID
NCT02285647
Treatments Being Tested
The objective of this Open Label Study is to evaluate effects of Rolapitant...
Status
Completed
Location
Parexel Early Phase Unit
Start Date
2015-05
Trial ID
NCT02434861
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, crossover, single c...
Status
Completed
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT00506545
Treatments Being Tested
This is a Phase 2, randomized, multicenter, parallel-group, double-blind, p...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00394966
Treatments Being Tested
The purpose of this phase 2 study is to assess the efficacy and patient sat...
Status
Completed
Location
The Preston Robert Tisch Brain Tumor Center at Duke
Start Date
2017-10-09
Trial ID
NCT02991456
Treatments Being Tested
This is a Phase 3, multicenter, randomized, parallel-group, double-blind, a...
Status
Completed
Location
TESARO Inc
Start Date
2012-02
Trial ID
NCT01500226
Treatments Being Tested